No black box warning on record for Minzoya

As of the latest FDA labeling reviewed, Minzoya (LEVONORGESTREL AND ETHINYL ESTRADIOL AND FERROUS BISGLYCINATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Minzoya medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Thrombotic Disorders and Other Vascular Problems : Stop Minzoya if a thrombotic event occurs. Stop at least 4 weeks before through 2 weeks after major surgery. Start no earlier than 4 weeks after delivery, in women who are not breastfeeding ( 5.1 ) Liver disease : Discontinue Minzoya if jaundice occurs ( 5.2 ) High Blood Pressure : If used in women with well- controlled

No black box warning on record for Minzoya

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Thrombotic Disorders and Other Vascular Problems : Stop Minzoya if a thrombotic event occurs. Stop at least 4 weeks before through 2 weeks after major surgery. Start no earlier than 4 weeks after delivery, in women who are not breastfeeding ( 5.1 ) Liver disease : Discontinue Minzoya if jaundice occurs ( 5.2 ) High Blood Pressure : If used in women with well- controlled

Minzoya Black Box Warning

No black box warning on record for Minzoya

Other warnings & precautions

Minzoya Black Box Warning

No black box warning on record for Minzoya

Other warnings & precautions